Research graph
References from Opioid use, disability, and patient‐reported cognitive impairment in migraine: Multi‐country results from the Chronic Migraine Epidemiology and Outcomes—International Study. Local targets link to admitted publications; unresolved targets remain external evidence.
10.18553/jmcp.2020.20100
10.18553/jmcp.2020.20100 · External reference
10.1007/s40120-020-00196-2
10.1007/s40120-020-00196-2 · External reference
10.1186/s10194-023-01655-5
10.1186/s10194-023-01655-5 · External reference
10.1111/head.14153
10.1111/head.14153 · External reference
10.1101/2025.04.03.25325136
10.1101/2025.04.03.25325136 · External reference
10.1007/s40120-024-00669-8
10.1007/s40120-024-00669-8 · External reference
10.1111/j.1468-1331.2009.02748.x
10.1111/j.1468-1331.2009.02748.x · External reference
10.1001/jama.2021.7939
10.1001/jama.2021.7939 · External reference
10.1212/01.wnl.0000335946.53860.1d
10.1212/01.wnl.0000335946.53860.1d · External reference
10.1007/s11916-009-0048-3
10.1007/s11916-009-0048-3 · External reference
10.1212/01.wnl.0000113747.18760.d2
10.1212/01.wnl.0000113747.18760.d2 · External reference
10.1186/s10194-018-0865-z
10.1186/s10194-018-0865-z · External reference
10.1212/wnl.0000000000009324
10.1212/wnl.0000000000009324 · External reference
10.1212/cpj.0000000000001037
10.1212/cpj.0000000000001037 · External reference
10.1016/j.mayocp.2019.11.025
10.1016/j.mayocp.2019.11.025 · External reference
10.1111/head.14018
10.1111/head.14018 · External reference
10.1111/j.1526-4610.2011.02050.x
10.1111/j.1526-4610.2011.02050.x · External reference
10.1111/head.14033
10.1111/head.14033 · External reference
10.1007/s40264-024-01506-5
10.1007/s40264-024-01506-5 · External reference
Unresolved reference
2015 · External reference
Chronic Migraine Epidemiology and Outcomes–International (CaMEO‐I) study: methods and multi‐country baseline findings for diagnosis rates and care
2023 · External reference
10.1177/0333102417738202
10.1177/0333102417738202 · External reference
10.1046/j.1526-4610.2001.041007646.x
10.1046/j.1526-4610.2001.041007646.x · External reference
10.1111/j.1526-4610.2012.02223.x
10.1111/j.1526-4610.2012.02223.x · External reference
10.1212/wnl.56.suppl_1.s20
10.1212/wnl.56.suppl_1.s20 · External reference
10.1111/j.1468-2982.2008.01786.x
10.1111/j.1468-2982.2008.01786.x · External reference
Unresolved reference
2023 · External reference
10.1111/head.12233
10.1111/head.12233 · External reference
10.1016/s0196-0644(19)31168-0
10.1016/s0196-0644(19)31168-0 · External reference
10.1212/wnl.0b013e31828aab14
10.1212/wnl.0b013e31828aab14 · External reference
10.1016/j.mayocp.2015.04.010
10.1016/j.mayocp.2015.04.010 · External reference
10.1111/j.1526-4610.2008.01217.x
10.1111/j.1526-4610.2008.01217.x · External reference
Duration and frequency of migraines affect cognitive function: evidence from neuropsychological tests and event‐related potentials
10.1186/s10194-017-0758-6 · 2017 · External reference
Depressive symptoms during the different phases of a migraine attack: a prospective diary study
10.1016/j.jad.2021.10.046 · 2022 · External reference
10.1212/wnl.54.2.308
10.1212/wnl.54.2.308 · External reference
10.1017/s0033291713002535
10.1017/s0033291713002535 · External reference
10.1212/wnl.0000000000004642
10.1212/wnl.0000000000004642 · External reference
10.1016/j.clinthera.2007.07.017
10.1016/j.clinthera.2007.07.017 · External reference
Characterizing opioid use in a Dutch cohort with migraine
2023 · External reference
10.1046/j.1468-2982.1994.1402156.x
10.1046/j.1468-2982.1994.1402156.x · External reference
10.1016/s0196-0644(98)70126-x
10.1016/s0196-0644(98)70126-x · External reference
The acute treatment of migraine with transnasal butorphanol (TNB)
1993 · External reference
10.1111/j.1526-4610.1995.hed3502065.x
10.1111/j.1526-4610.1995.hed3502065.x · External reference
10.1111/j.1526-4610.1993.hed3310560.x
10.1111/j.1526-4610.1993.hed3310560.x · External reference
10.1016/s0196-0644(89)80570-0
10.1016/s0196-0644(89)80570-0 · External reference
10.1053/ajem.2002.30007
10.1053/ajem.2002.30007 · External reference
10.1111/j.1526-4610.1995.hed3505256.x
10.1111/j.1526-4610.1995.hed3505256.x · External reference
10.1111/j.1526-4610.2005.00264.x
10.1111/j.1526-4610.2005.00264.x · External reference
10.1016/s0196-0644(05)81471-4
10.1016/s0196-0644(05)81471-4 · External reference
10.3923/pjbs.2011.682.687
10.3923/pjbs.2011.682.687 · External reference
Real‐world assessment of concomitant opioid utilization and associated trends in patients with migraine
10.37765/ajmc.2020.42544 · 2020 · External reference
10.1111/head.12074
10.1111/head.12074 · External reference
10.1111/j.1526-4610.2008.01282.x
10.1111/j.1526-4610.2008.01282.x · External reference
10.1111/head.12645
10.1111/head.12645 · External reference
10.1177/0333102414539055
10.1177/0333102414539055 · External reference
10.1177/0333102410378178
10.1177/0333102410378178 · External reference
10.3390/jcm11051401
10.3390/jcm11051401 · External reference
10.1111/head.12835
10.1111/head.12835 · External reference
10.1016/j.ajem.2019.06.011
10.1016/j.ajem.2019.06.011 · External reference
Trends in opioids prescribed at discharge from emergency departments among adults: United States, 2006–2017
2020 · External reference
10.1177/2514183x18823377
10.1177/2514183x18823377 · External reference
International headache society global practice recommendations for the acute pharmacological treatment of migraine
10.1177/03331024241252666 · 2024 · External reference
Revised guidelines of the French Headache Society for the diagnosis and management of migraine in adults. Part 2: pharmacological treatment
10.1016/j.neurol.2021.07.006 · 2021 · External reference
10.1017/s0317167100118943
10.1017/s0317167100118943 · External reference
